CHV in the Press:
Biotia - A CHV portfolio raises U$8M Series A
Aug 23, 2023
Biotia, a company fighting infectious diseases powered by genomics and artificial intelligence (AI), has raised an oversubscribed $8 million Series A round led by OCA Ventures. OCA, a veteran early stage venture firm operating from Chicago and Palo Alto was joined by other key investors including Continuum Health Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Digital-Dx Ventures, and others. Prior Seed round investors include Falcon II Ventures, Tau Ventures, Hyperplane Venture Capital, Leawood Venture Capital, SpringTide Ventures, and others.
Immunis - A CHV portfolio raises U$10M Series A
Aug 3, 2023
Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, has closed a $10M Series A First Closing financing led by Remiges Ventures with participation by several other healthcare investment firms. Strategic investor, Continuum Health Ventures, which supports thesis-driven startups at the intersection of health and technology in the digital health and longevity sectors, also joined the round. Proceeds will support clinical assessment of Immunis’ immunomodulatory secretome product in an FDA-awarded Phase 1/2a clinical trial targeting muscle atrophy, which is an age, disuse and disease-associated condition experienced by 100% of the population.
BeeKeeperAI Raises $12.1M in Series A Funding
Jun 28, 2023
BeeKeeperAI, a San Francisco, CA-based provider of zero-trust, collaboration software for the development and deployment of artificial intelligence (AI), raised $12.1M in Series A funding.
The round was led by Sante Ventures, with participation from Continuum Health Ventures, the Icahn School of Medicine at Mount Sinai, AIX Ventures, TA Group Holdings, and UCSF.
BeekeeperAI also announced announced the general availability of EscrowAI, a patent-protectedi zero-trust collaboration platform. EscrowAI leverages Azure confidential computing to resolve the challenges of data sovereignty, privacy, and security. In healthcare, EscrowAI enables HIPAA-compliant research on full PHI without exposing the patient data, thereby reducing the AI development timeline dramatically due to streamlined collaboration agreements and access to more precise data.
Sanctuary AI rolls out Phoenix, a Carbon-based humanoid AI labor robot
May 5, 2023
Sanctuary AI has revealed a new humanoid robot, shooting for the "world's first human-like intelligence in general purpose robots (GPR). The first commercially available, general-purpose robot of its kind: a 5-foot, 7-inch working machine named Phoenix, is powered by an advanced AI software system called Carbon.
Phoenix features dexterous hands intended to perform tasks ranging from stocking shelves to unloading a truck to working a register to many healthcare applications.
DeepWell DTx's founder launches Medicinal Media, highlights links between games and healing
May 5, 2023
DeepWell Digital Therapeutics (DTx) cofounder Mike Wilson has started Medicinal Media, a nonprofit group and media publication that highlights the connection between games and healing. The goal is to illuminate the art and science of “beneficial media” with an emphasis on mental health.
Enara Health a CHV portfolio raises U$6M Seed
Jun 27, 2022
Enara Health, the holistic weight management platform that is building a healthcare network to scale medical obesity treatment announced today $6M in seed funding led by Offline.VC and with Charge.VC, Crossover.VC, ContinuumHealth.VC, VSC Ventures, and notable angels including Raj Kapoor, Kevin Mahaffey, and Matt Brezina. Combined, these investors bring experience in top companies such as Tonal, Lyft, ClassPass, and FitMob. The funds will be used to scale Enara's medical obesity treatment and expand its current network of 30 healthcare providers and specialists.
New Video Game Company Aims to Develop Therapeutic Games
Mar 15, 2022
Video game-based tools can help with conditions like depression and ADHD, research shows. DeepWell Digital Therapeutics plans to build on those studies. “There was an amazing amount of science that had already been done,” Douglas says. “We started to recognize exactly how therapeutic these games already were.”
Sanctuary.AI - A CHV portfolio raises U$58.5M Series A
Mar 2, 2022
Sanctuary Cognitive Systems Closes C$75.5 Million (US$58.5 Million) Series A Funding, Accelerating its Mission to Create the World’s First Human-Like Intelligence in General-Purpose Robots to Address Labour Shortages Around the World
Supervised by people, Sanctuary general-purpose robots will improve the nature of work and strengthen the global economy.
Vancouver, Canada – March 2, 2022, Sanctuary Cognitive Systems Corporation, a company focused on creating the world’s first human-like intelligence in general-purpose robots, today announced the successful closing of an oversubscribed C$75.5 million (US$58.5 million) Series A funding.
2021: A Year of Transformation by Dr. Daniel Kraft
Feb 27, 2022
In this address, Dr. Daniel Kraft revisits his discussions with the health care industry’s leading voices on topics that range from sickle cell disease (redefining the red blood cell) to the data supply chain to preeclampsia and ‘physician culture.’ Daniel also takes a long look forward at the ways health care will continue to evolve as an industry in 2022, creating a system that’s more proactive, equitable, and collaborative. We learned a lot from our guests on Healthy Conversations last year, thank you to all of our guests and a very special thank you to all health care professionals who work so hard to care for us all.
Daniel Kraft: How COVID-19 transformed the future of medicine | TED
Jun 4, 2021
The pandemic forced the world to work together like never before and, with unprecedented speed, bore a new age of health and medical innovation. Physician-scientist Daniel Kraft explains how breakthroughs and advancements like AI-infused antiviral discoveries and laboratory-level diagnostic tools accessible via smartphones are paving the way for a more democratized, connected and data-driven future of medicine and personalized care.